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Methamphetamine is a stimulant drug that has 
been around for decades. Its popularity has waxed 
and waned over the years, but its use seems 
to be increasing in many parts of the United 
States and in several population subgroups. 
Methamphetamine is very addictive, it can be 
injected, and it can increase sexual arousal while 
reducing inhibitions. Because of these attributes, 
public health officials are concerned that users 
may be putting themselves at increased risk of 
acquiring or transmitting HIV infection―a valid 
concern, considering that methamphetamine use 
has been linked with increased numbers of HIV 
infections in some populations [1].
There is a growing body of research on 
methamphetamine use among men who have sex 
with men (MSM). Overall, assessments show that 
MSM who use methamphetamine may increase 
their sexual risk factors (for example, they may use 
condoms less often, have more sex partners, and 
may engage in practices that elevate their risk for 
HIV infection, such as unprotected receptive anal 
sex) and perhaps their HIV-related drug-use risk 
factors (for example, injecting methamphetamine 
instead of smoking or snorting it) [1].
MSM are not the only group with risk factors 
related to methamphetamine use. Evidence shows 
that heterosexual adults and adolescents under the 
influence of methamphetamine may also engage in 
practices that increase their risk for HIV infection 
and other sexually transmitted diseases (STDs) [2]. 
However, among MSM, the baseline prevalence of 
infections (such as HIV) and risk behaviors (such 
as number of partners and anal sex) tends to be 
higher, resulting in greater risk for transmission. 
Methamphetamine users may exchange sex for 
money or drugs, creating another risk factor for 
acquiring and transmitting HIV [2].
What is becoming clear is that the use of 
methamphetamine can contribute to sexual risk 
behaviors, regardless of the sexual orientation 
of the user. Current data indicate a strong link 
between methamphetamine use and sexual risk 
among MSM, and perhaps among heterosexual 
adults and youth.
The following are facts about methamphetamine, 
its effects on the body, and research showing its 
role in increasing behaviors that put persons at risk 
of acquiring or transmitting HIV infection.
 
Methamphetamine Defined
Methamphetamine is a central nervous system 
stimulant categorized by the U.S. Food and Drug 
Administration as a Schedule II amphetamine, 
which means it has a high potential for abuse and 
for psychological or physical dependence. There 
are numerous slang names for methamphetamine, 
some of which are regional or group-specific. The 
most common are meth, crystal meth, Tina, ice, 
and glass. Methamphetamine is smoked, injected, 
snorted, swallowed, or inserted into the anus [3].
How Methamphetamine Is Produced
Methamphetamine can be produced through a 
series of fairly simple chemical steps involving 
a common decongestant―ephedrine or pseudo-
ephedrine―in combination with products such 
as iodine crystals, battery acid, red phosphorous, 
and anhydrous ammonia. It can be formulated as 
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a liquid, a powder, a waxy solid (glass), or a clear 
rock (ice).
Methamphetamine Use in the United 
States
According to the Substance Abuse and Mental 
Health Services Administration (SAMHSA), in 
2004,
an estimated 12 million persons aged 12 and 
older (4.9% of US persons aged 12 or older) 
had used methamphetamine at least once in 
their lifetime
1.4 million persons aged 12 or older (0.6% of 
the US population) had used methamphetamine 
during the past year
600,000 (0.2% of the US population) had used 
it during the past month [4].
SAMHSA estimated that from 1993 through 
2003, the rate of admissions for the treatment 
of methamphetamine or amphetamine abuse 
increased from 13 to 56 admissions per 100,000 
for people aged 12 or older [5].
Studies show a higher prevalence of 
methamphetamine use among MSM than among 
the general population. For example, in a study of 
urban, young MSM (aged 15-22 years), conducted 
during 1994–1998, 20% of the participants 
reported having used methamphetamine during 
the past 6 months [6]. A 2001 study found 
that 15% of MSM in San Francisco had used 
methamphetamine during their most recent 
anal sex (within the past 3 months)―making 
methamphetamine use third only to the prevalence 
of alcohol and marijuana use [7].
The current increase (since the early 1990s) 
of methamphetamine use began in the western 
United States. However by the mid-2000s, its use 
had become a nationwide concern. The National 
Clandestine Laboratory Database, which includes 
the number of clandestine labs seized, showed an 
increase in the number of lab seizures in almost 
•
•
•
every state from 2000 through 2005 [8]. As of 
2004, the rates of methamphetamine use were 
particularly high in the western states: 12 states, 
including California, Nevada, Wyoming, and 
Montana, ranked in the top third of states in terms 
of methamphetamine use during the past year [4].
Lab seizures and restrictions on purchasing 
ingredients have reduced the production of 
methamphetamine in the United States.
The Effects of Methamphetamine 
Use
As a central nervous system stimulant, 
methamphetamine directly affects the brain and 
the spinal cord by interfering with the normal 
release and uptake of neurotransmitters (chemicals 
that nerve and brain cells produce to communicate 
with each other). Dopamine is the primary 
neurotransmitter affected by methamphetamine, 
but norepinephrine and epinephrine are also 
affected.
The use of methamphetamine causes the release 
of large quantities of neurotransmitters. The 
neurotransmitters, in turn, cause increased heart 
rate and blood pressure levels and produce 
sensations of pleasure, self-confidence, energy, 
and alertness. They also suppress the appetite 
and enhance sexual arousal. Users may report 
sleeplessness, talkativeness, teeth grinding, 
increased body temperature, and compulsive 
behavior, such as skin picking.
Long-term use can cause physical symptoms 
(decayed teeth, weight loss, skin lesions, stroke, 
and heart attack) as well as mental symptoms 
(paranoia, hallucinations, anxiety, and irritability) 
and behavioral symptoms (aggressiveness, 
violence, and isolation).
The long-term use of methamphetamine 
can lead to reduced levels of dopamine and 
other neurotransmitters, making the user 
crave methamphetamine to raise dopamine 
levels. Because bingeing on the drug depletes 
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neurotransmitter stores, coming down from 
the high is often described as a “crash,” which 
includes a phase of depression. Additional doses of 
methamphetamine are often used to alleviate these 
negative feelings. This cycle can lead to addiction, 
which can be very difficult to overcome.
Because methamphetamine use can cause 
impotence at the same time that it is increasing 
libido, some MSM may use erectile dysfunction 
medications and may then engage in unprotected 
receptive or insertive anal sex while under the 
influence of the drugs [7]. 
How Methamphetamine Compares 
with Amphetamines or Cocaine
Changes in specific parts of the brain of 
methamphetamine users are similar to those of 
cocaine and other substance users; however, 
methamphetamine, amphetamines, and cocaine 
differ in some ways.
For example, compared with amphetamines, 
methamphetamine has longer lasting and 
more toxic effects. Methamphetamine is also 
stronger and longer lasting than cocaine. 
Methamphetamine, compared with cocaine, 
causes a more than 3-fold release of dopamine in 
the brain and has a half-life (the amount of time 
necessary for half of the drug to be metabolized) 
of 12 hours, compared with cocaine’s half-life 
of 1 hour. If smoked, it can produce a high for 
8–24 hours; smoking cocaine produces a high 
for approximately 20–30 minutes [9]. Because 
its effects last longer and it is less expensive 
than cocaine, methamphetamine is attractive to 
many populations, including young people, who 
sometimes refer to it as “poor man’s cocaine.”
The Methamphetamine User
There is no typical methamphetamine user. The 
drug is used by people of different ages and 
races, in all parts of the country, and for different 
reasons. However, some trends have been noted in 
the United States.
Age: Many methamphetamine users are young. 
Because it is cheaper and longer lasting than 
cocaine, methamphetamine is becoming 
popular with persons in their teens and early 
20s [10, 11]. The average age at first use was 
18.9 years in 2002, 20.4 years in 2003, and 
22.1 years in 2004 [4]. The highest rate of 
methamphetamine use during the past year was 
that for young adults aged 18 to 25, followed 
by youth aged 12 to 17, and then adults aged 
26 or older [4].
Sex: Among all persons 12 years of age or 
older, the rate of use during the past year was 
about the same for males and females (0.7% 
and 0.5%, respectively) [4].
Race/ethnicity: The largest numbers 
methamphetamine users are white. However, 
the highest rates of methamphetamine use 
during the past year were those for Native 
Hawaiians or other Pacific Islanders (2.2%), 
American Indians or Alaska Natives (1.7%), 
and person who reported 2 or more races 
(1.9%). Past-year use among whites (0.7%) 
and Hispanics (0.5%) was higher than among 
African Americans (0.2%). [4].
MSM: According to data from the 2004 
CDC National HIV Behavioral Surveillance 
System, overall, a higher percentage of 
MSM methamphetamine users compared 
to non-users were white (50.4% vs. 43.5% 
respectively) [10].
Rural users: Many methamphetamine 
users in rural areas are white, working class, 
heterosexual young adults [12]. Trends in 
rural areas show that increasing numbers of 
Latinos, Native Americans and youth are using 
methamphetamine. Rural users, compared with 
urban users, are more likely to be heterosexual 
[12].
Reasons For Methamphetamine Use
The reasons for using methamphetamine vary.
Males and females have reported using 
methamphetamine for increased energy and 
•
•
•
•
•
•
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productivity, its low cost, self-medication 
for depression or attention deficits, and the 
euphoric high [13,14].
Males have reported using methamphetamine 
for economic reasons, (selling the drug, 
increased energy to work multiple jobs) 
and sexual reasons (enhanced libido and 
endurance) [11, 14].
A study of HIV-positive MSM who use 
methamphetamine found that the most 
frequently reported motivation for use was to 
enhance sexual pleasure (reported by nearly 
90% of respondents) [13]. Other reasons 
included self-medication of negative feelings 
associated with HIV-positive serostatus.
A similar study of HIV-negative heterosexual 
adults found that the primary motivations for 
methamphetamine use were to get high, to get 
more energy, and to party [14].
Females reported using methamphetamine to 
control weight and to combat fatigue [12].
The culture of methamphetamine use provides 
a social network―a community―for persons 
who feel like outsiders [12].
Methamphetamine Use and HIV Risk 
Behaviors
A growing body of research supports the 
relationship between methamphetamine use 
by MSM and heterosexual populations and an 
increase in behaviors (sexual and those related to 
injection drug use) that can put the user at risk for 
HIV infection.
A survey of users of noninjection drugs, 
conducted in California during the mid-1990s, 
showed that heterosexual persons and MSM 
who reported using methamphetamine also 
had more sex partners, were less likely to use a 
condom, and were more likely to exchange sex 
for money or drugs, have sex with an injection 
drug user, or to have a history of STD―all risk 
factors for HIV transmission [2]. 
•
•
•
•
•
•
A qualitative study of gay and bisexual men in 
Seattle (Washington) and San Jose (California), 
conducted during 1997–2001, revealed a high 
prevalence of club drugs (methamphetamine, 
ecstasy, ketamine, and GHB [gamma hydroxyl 
butyrate]) in tandem with unsafe sex practices. 
Many of the respondents reported that they 
already had HIV infection or AIDS and that 
they “medicated” their symptoms through their 
drug use. Respondents reported engaging in 
unprotected sex as well as trading sex for drugs 
[15].
A 2001 study conducted among gay and 
bisexual men in the San Francisco Bay 
Area showed that of MSM who participated 
in circuit party weekends, those who used 
methamphetamine were more than twice as 
likely to have unprotected anal sex during that 
weekend with a partner whose HIV status was 
unknown or different from theirs [16].
According to a 1998 study conducted at 
publicly funded HIV testing sites in California, 
HIV-positive MSM may be more likely than 
HIV-negative MSM to use methamphetamine, 
and some MSM methamphetamine users may 
be more likely than other methamphetamine 
users to use it during sex [2].
An analysis of data of heterosexual men, 
performed by the California Department of 
Health Services during 2001–2003 determined 
that recent methamphetamine use was 
associated with high-risk sexual behaviors, 
including anal intercourse, sex with an 
injection drug user, and sex with a casual or an 
anonymous female partner [17].
In California, 9.5% of primary and secondary 
syphilis cases in heterosexual men during 
2004 were cases in men with a history of 
methamphetamine use, continuing a trend of 
increases in syphilis cases, from 3.1% in 2001, 
6.4% in 2002, and 7.3% in 2003 [18]. Syphilis 
infection is a marker for unprotected sex, a risk 
factor for HIV infection.
During a gonorrhea outbreak in 6 central 
California counties in 2004, substantial 
•
•
•
•
•
•
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proportions of heterosexual men (38%) and 
women (28%) reported methamphetamine use, 
particularly when compared with MSM (8%) 
[17]. Like syphilis, gonorrhea infection is a 
marker for unprotected sex, a risk factor for 
HIV infection.
Some evidence suggests that the use 
of methamphetamine (not injected) by 
heterosexual men and women is associated 
with unprotected vaginal sex and with a higher 
number of sex partners during the past 12 
months [2].
In addition to increasing sexual risk factors, 
methamphetamine use increases the risk for 
HIV transmission when the drug is injected. For 
example, women reported being injected with 
methamphetamine by sex partners, often with 
a shared syringe [18]. According to a Colorado 
study, people who injected methamphetamine 
more frequently shared syringes during a 
methamphetamine binge [18].
Specific Ways Methamphetamine 
Use Negatively Affects Thinking and 
Behavior
Methamphetamine use may impair the ability 
or the desire to be safe, both sexually and when 
injecting drugs. That impairment, in turn, may 
lead to experimentation with riskier behaviors in 
general.
Methamphetamine may dry mucosa, which 
may lead to more chafing and abrasions, which, 
in turn, could provide an entry for HIV during 
sexual activity.
Methamphetamine use is associated with sexual 
practices that may increase the likelihood of HIV 
and other STD transmission (e.g., long duration, 
leading to chafing or sores; multiple partners; 
lack of inhibition; low level of condom use).
Methamphetamine use may cause mental 
confusion and impair the ability to take 
medications that have been prescribed for HIV 
infection or other conditions.
•
•
•
•
•
Public Health Implications
Methamphetamine use is a public health issue. 
There is a need for a broad approach in addressing 
methamphetamine use and risk for infection 
with HIV and other STDs―one that includes 
heterosexual adults and adolescents as well as 
MSM. HIV and STD prevention and treatment 
programs could be enhanced to include assessment 
for methamphetamine use, with referrals to 
methamphetamine treatment, primary testing, and 
sexual health promotion.
REFERENCES
Buchacz K, McFarland W, Kellogg TA, et al. 
Amphetamine use is associated with increased HIV 
incidence among men who have sex with men in San 
Francisco [Research Letters]. AIDS 2005;19:1423–1424.
Molitor F, Truax SR, Ruiz JD, Sun RK. Association 
of methamphetamine use during sex with risky sexual 
behaviors and HIV infection among non-injection drug 
users. Western Journal of Medicine 1998;168:93–97.
Substance Abuse and Mental Health Services 
Administration, Office of Applied Studies. 
Methamphetamine/amphetamine and other stimulants. 
In: Treatment Episode Data Set (TEDS), 1992–2002: 
National Admissions to Substance Abuse Treatment 
Services. Rockville, Md: Substance Abuse and Mental 
Health Services Administration; 2004:40. DASIS Series 
S-23, DHHS Publication No. (SMA) 04-3965. Also 
available at http://wwwdasis.samhsa.gov/teds02/2002_
teds_rpt.pdf. Accessed December 11, 2006.
Substance Abuse and Mental Health Services 
Administration, Office of Applied Studies. The NSDUH 
report: methamphetamine use, abuse, and dependence: 
2002, 2003, and 2004. September 16, 2005. Available at 
http://oas.samhsa.gov/2k5/meth/meth.pdf.  
Accessed December 11, 2006.
Substance Abuse and Mental Health Services 
Administration, Office of Applied Studies. The DASIS 
report: trends in methamphetamine/amphetamine 
admissions to treatment, 1993–2003. 2006. Available 
at http://oas.samhsa.gov/2k6/methTx/methTX.cfm. 
Accessed December 11, 2006.
Thiede H, Valleroy LA, MacKellar DA, et al. Regional 
patterns and correlates of substance use among young 
men who have sex with men in 7 US urban areas. 
American Journal of Public Health 2003;93:1915–1921.
Mansergh G, Shouse RL, Marks G, et al. 
Methamphetamine and sildenafil (Viagra) use are 
1.
2.
3.
4.
5.
6.
7.
 

Methamphetamine Use and Risk for HIV/AIDS
linked to unprotected receptive and insertive anal sex, 
respectively, in a sample of men who have sex with men. 
Sexually Transmitted Infections 2006;82:131–134.
U.S. Drug Enforcement Administration. Maps of 
methamphetamine laboratory incidents: calendar years 
1999–2005. Available at http://www.usdoj.gov/dea/
concern/map_lab_seizures.html.  
Accessed December 12, 2006.
National Institutes of Health, National Institute on 
Drug Abuse. Methamphetamine: Abuse and Addiction. 
Rockville, Md: National Institute on Drug Abuse; 
September 2006 (rev). Research Report Series, NIH 
Publication No. 06-4210. Also available at http://www.
nida.nih.gov/PDF/RRMetham.pdf.  
Accessed December 11, 2006.
Mansergh G, Purcell DW, Stall R, et al. CDC 
consultation on methamphetamine use and sexual 
risk behavior for HIV/STD infection: summary and 
suggestions. Public Health Reports 2006;121:127–132.
KCI, the Anti-Meth Site. Methamphetamine frequently 
asked questions. Available at http://www.kci.org/meth_
info/faq_meth.htm. Accessed December 11, 2006.
Rural Center for AIDS/STD Prevention. Rural 
methamphetamine use and HIV/STD risk. 2006. Fact  
sheet No. 18. Available at http://www.indiana.edu/~aids/
factsheets18.pdf Accessed December 11, 2006. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.
9.
10.
11.
12.
Semple SJ, Patterson TL, Grant I. Motivations 
associated with methamphetamine use among HIV+ 
men who have sex with men. Journal of Substance 
Abuse Treatment 2002;22:149–156.
Semple, SJ, Patterson TL, Grant I. The context of sexual 
risk behavior among heterosexual methamphetamine 
users. Addictive Behaviors 2004;29:807–810.
Gorman EM, Nelson KR, Applegate T, et al. Club drug 
and poly-substance abuse and HIV among gay/bisexual 
men: lessons gleaned from a community study. Journal 
of Gay & Lesbian Social Services 2004;16:1–17.
Colfax GN, Mansergh G, Guzman R, et al. Drug use 
and sexual risk behavior among gay and bisexual men 
who attend circuit parties: a venue-based comparison. 
Journal of Acquired Immune Deficiency Syndromes 
2001;28:373–379.
CDC. Methamphetamine use and HIV risk behaviors 
among heterosexual men―preliminary results from 
five northern California counties, December 2002–
November 2003. MMWR 2006;55:273–277.
Dreisbach SL, Hickler B, Koester S. Methamphetamine 
use in rural Colorado: health risks and community 
challenges. Association of Preventive Medicine; 2004.
13.
14.
15.
16.
17.
18.
For more information . . . 
CDC HIV/AIDS 
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http://www.cdcnpin.org
CDC resources, technical assistance, and 
publications
AIDSinfo
1-800-8-00 
http://www.aidsinfo.nih.gov
Resources on HIV/AIDS treatment and  
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